Recurrent Campylobacter jejuni Infections with


Journal

Microbiology spectrum
ISSN: 2165-0497
Titre abrégé: Microbiol Spectr
Pays: United States
ID NLM: 101634614

Informations de publication

Date de publication:
17 08 2023
Historique:
medline: 21 8 2023
pubmed: 26 6 2023
entrez: 26 6 2023
Statut: ppublish

Résumé

We present two independent cases of recurrent multidrug-resistant Campylobacter jejuni infection in immunocompromised hosts and the clinical challenges encountered due to the development of high-level carbapenem resistance. The mechanisms associated with this unusual resistance for

Identifiants

pubmed: 37358443
doi: 10.1128/spectrum.01070-23
pmc: PMC10434052
doi:

Substances chimiques

Macrolides 0
Carbapenems 0
Ertapenem G32F6EID2H
Anti-Bacterial Agents 0

Types de publication

Journal Article Research Support, Non-U.S. Gov't

Langues

eng

Sous-ensembles de citation

IM

Pagination

e0107023

Déclaration de conflit d'intérêts

The authors declare no conflict of interest.

Références

J Antimicrob Chemother. 2006 Aug;58(2):243-55
pubmed: 16735431
Intern Med. 2018 Jul 15;57(14):2077-2080
pubmed: 29491300
J Mol Biol. 2016 Nov 6;428(22):4528-4543
pubmed: 27693650
Cold Spring Harb Perspect Biol. 2015 Jun 22;7(8):a018119
pubmed: 26101080
Clin Infect Dis. 2005 Jul 15;41 Suppl 2:S120-6
pubmed: 15942878
Nat Commun. 2019 Sep 2;10(1):3957
pubmed: 31477712
Eur J Clin Microbiol Infect Dis. 2004 Sep;23(9):718-21
pubmed: 15338445
Antimicrob Agents Chemother. 2005 Mar;49(3):1067-75
pubmed: 15728904
Proc Natl Acad Sci U S A. 2016 Sep 20;113(38):10690-5
pubmed: 27601641
FEMS Microbiol Lett. 2007 Dec;277(2):123-32
pubmed: 18031331
Clin Microbiol Rev. 2015 Jul;28(3):687-720
pubmed: 26062576
Ann Intern Med. 1982 Feb;96(2):187-8
pubmed: 7059067
Dermatol Ther. 2021 Nov;34(6):e15176
pubmed: 34704344
Future Microbiol. 2009 Mar;4(2):189-200
pubmed: 19257846
Antimicrob Agents Chemother. 2009 Aug;53(8):3357-64
pubmed: 19506058
J Antimicrob Chemother. 2014 May;69(5):1215-23
pubmed: 24408987
Antimicrob Agents Chemother. 2007 Sep;51(9):3212-6
pubmed: 17606685
Antimicrob Agents Chemother. 2021 Oct 18;65(11):e0112421
pubmed: 34370579
Bioinformatics. 2014 Aug 1;30(15):2114-20
pubmed: 24695404
Nucleic Acids Res. 2004 Jul 1;32(Web Server issue):W400-4
pubmed: 15215419
Bioinformatics. 2004 Nov 22;20(17):3258-60
pubmed: 15201184
J Bacteriol. 1998 Feb;180(3):594-9
pubmed: 9457862
Antimicrob Agents Chemother. 2000 Feb;44(2):267-71
pubmed: 10639348
Antimicrob Agents Chemother. 2007 May;51(5):1678-86
pubmed: 17353243
Microbiology (Reading). 2020 Mar;166(3):230-232
pubmed: 32228803
Clin Microbiol Rev. 2008 Jul;21(3):505-18
pubmed: 18625685
Biochim Biophys Acta. 2009 May;1794(5):826-33
pubmed: 19150515
Nat Rev Gastroenterol Hepatol. 2011 Oct 25;8(12):669-85
pubmed: 22025030
Clin Microbiol Rev. 2012 Oct;25(4):661-81
pubmed: 23034325
J Antimicrob Chemother. 2005 Sep;56(3):491-7
pubmed: 16055509
J Antimicrob Chemother. 2004 Jan;53(1):28-52
pubmed: 14657094
EFSA J. 2021 Dec 13;19(12):e06971
pubmed: 36329690
Antimicrob Agents Chemother. 2005 Jun;49(6):2515-8
pubmed: 15917560
Sci Rep. 2020 Jun 22;10(1):10109
pubmed: 32572150
Microbiol Spectr. 2018 Apr;6(2):
pubmed: 29623873
PLoS One. 2011;6(10):e25825
pubmed: 22053181
Appl Environ Microbiol. 2017 Mar 17;83(7):
pubmed: 28115376
J Comput Biol. 2012 May;19(5):455-77
pubmed: 22506599
Antimicrob Agents Chemother. 2003 Dec;47(12):3825-30
pubmed: 14638490
EMBO J. 2003 Feb 17;22(4):945-53
pubmed: 12574130
Transpl Infect Dis. 2014 Dec;16(6):1007-11
pubmed: 25296529
Soft Matter. 2021 Mar 18;17(10):2725-2736
pubmed: 33533373
Nat Biotechnol. 2011 Jan;29(1):24-6
pubmed: 21221095
Nat Microbiol. 2018 Apr;3(4):494-502
pubmed: 29588538
West J Med. 1994 Aug;161(2):148-52
pubmed: 7941533
Antimicrob Agents Chemother. 2008 Nov;52(11):3947-54
pubmed: 18779354
Clin Infect Dis. 2022 Sep 10;75(4):702-709
pubmed: 34849656
PLoS One. 2014 Nov 19;9(11):e112963
pubmed: 25409509
Genetics. 2000 Jun;155(2):945-59
pubmed: 10835412
Clin Microbiol Infect. 2011 Nov;17(11):1735-9
pubmed: 21375659
Antimicrob Agents Chemother. 1989 Mar;33(3):297-303
pubmed: 2543277
J Antimicrob Chemother. 2003 Dec;52(6):1035-9
pubmed: 14613954

Auteurs

Alexandra Nunes (A)

Infectious Diseases Department, National Institute of Health Dr. Ricardo Jorge (INSA), Lisbon, Portugal.
Faculty of Veterinary Medicine, Lusófona University, Lisbon, Portugal.

Mónica Oleastro (M)

Infectious Diseases Department, National Institute of Health Dr. Ricardo Jorge (INSA), Lisbon, Portugal.

Frederico Alves (F)

Infectious Diseases Department, National Institute of Health Dr. Ricardo Jorge (INSA), Lisbon, Portugal.

Nadia Liassine (N)

Laboratoire Dianalabs, Geneva, Switzerland.

David M Lowe (DM)

University College London, London, United Kingdom.

Lucie Benejat (L)

French National Reference Centre for Campylobacters and Helicobacters, Bordeaux Hospital University Centre, Bordeaux, France.

Astrid Ducounau (A)

French National Reference Centre for Campylobacters and Helicobacters, Bordeaux Hospital University Centre, Bordeaux, France.

Quentin Jehanne (Q)

French National Reference Centre for Campylobacters and Helicobacters, Bordeaux Hospital University Centre, Bordeaux, France.

Vítor Borges (V)

Infectious Diseases Department, National Institute of Health Dr. Ricardo Jorge (INSA), Lisbon, Portugal.

João Paulo Gomes (JP)

Infectious Diseases Department, National Institute of Health Dr. Ricardo Jorge (INSA), Lisbon, Portugal.
Faculty of Veterinary Medicine, Lusófona University, Lisbon, Portugal.

Gauri Godbole (G)

UK Health Security Agency, London, United Kingdom.

Lehours Philippe (L)

French National Reference Centre for Campylobacters and Helicobacters, Bordeaux Hospital University Centre, Bordeaux, France.
University of Bordeaux, INSERM, Bordeaux Institute of Oncology, Bordeaux, France.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH